PLATELET-ACTIVATING-FACTOR ANTAGONIST BN52021 IMPROVES SURVIVAL IN NORMOTHERMIC LIVER ISCHEMIA IN RATS

被引：0
|
作者：
BOROBIA, FG [1 ]
FIGUERAS, J [1 ]
ESCRIBA, JM [1 ]
FARRAN, L [1 ]
RAFECAS, A [1 ]
FABREGAT, J [1 ]
TORRAS, J [1 ]
JAURRIETA, E [1 ]
机构：
[1] UNIV BARCELONA,DEPT GEN SURG,LIVER TRANSPLANT UNIT,BARCELONA 7,SPAIN
来源：
TRANSPLANTATION PROCEEDINGS | 1993年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2543 / 2544
页数：2
相关论文
共 50 条
  • [1] THE EFFECT OF PLATELET ACTIVATING FACTOR AND BN52021, A PLATELET ACTIVATING ANTAGONIST, ON THE BIOLOGY OF LYMPHOCYTES
    GEBHARDT, BM
    BRAQUET, P
    BAZAN, HEP
    BAZAN, NG
    FASEB JOURNAL, 1988, 2 (05): : A1239 - A1239
  • [2] THE EFFECT OF PLATELET ACTIVATING FACTOR AND BN52021, A PLATELET ACTIVATING ANTAGONIST, ON THE BIOLOGY OF LYMPHOCYTES
    GEBHARDT, BM
    BRAQUET, P
    BAZAN, HEP
    BAZAN, NG
    PROSTAGLANDINS, 1988, 35 (05): : 824 - 824
  • [3] PLATELET ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONIST, BN52021, IMPROVES SURVIVAL AND INHIBITS PROSTAGLANDIN RELEASE IN ENDOTOXEMIA
    FLETCHER, JR
    DISIMONE, AG
    EARNEST, MA
    BRAQUET, P
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1988, 28 (07): : 1085 - 1085
  • [4] MODIFICATION OF THE LATE ASTHMATIC RESPONSE AND BRONCHIAL HYPERREACTIVITY BY BN52021, A PLATELET-ACTIVATING-FACTOR ANTAGONIST
    COYLE, A
    SJOERDSMA, K
    PAGE, C
    BROWN, L
    METZGER, WJ
    CLINICAL RESEARCH, 1987, 35 (03): : A254 - A254
  • [5] EFFECT OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN52021 IN RABBITS - ROLE IN GENTAMICIN-NEPHROTOXICITY
    HANSLIK, T
    BLANCHET, F
    NOCHY, D
    PIROTZKY, E
    GUILMARD, C
    SETA, N
    CARBON, C
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 128 (01) : 111 - 115
  • [6] EFFECTS OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN 52021 ON THE HEMODYNAMICS OF RATS WITH EXPERIMENTAL CIRRHOSIS OF THE LIVER
    VILLAMEDIANA, LM
    SANZ, E
    FERNANDEZGALLARDO, S
    CARAMELO, C
    CRESPO, MS
    BRAQUET, P
    LOPEZNOVOA, JM
    LIFE SCIENCES, 1986, 39 (03) : 201 - 205
  • [7] CONCENTRATION DEPENDENT INHIBITION OF ISCHEMIA-REPERFUSION CEREBRAL INJURY WITH IMPROVED SURVIVAL BY INTRACRANIAL INJECTION OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST (BN52021)
    COHEN, FS
    PANETTA, TF
    VEITH, FJ
    MACKEY, KC
    SUGGS, WD
    WENGERTER, KR
    MARIN, ML
    FASEB JOURNAL, 1993, 7 (04): : A854 - A854
  • [8] BN52021, A PLATELET-ACTIVATING-FACTOR ANTAGONIST, BLOCKS PULMONARY-HYPERTENSION AND EDEMA INDUCED BY PLATELET-ACTIVATING-FACTOR IN ISOLATED PERFUSED RAT LUNGS
    IMAI, T
    VERCELLOTTI, GM
    JACOB, HS
    MOLDOW, CF
    WEIR, EK
    CLINICAL RESEARCH, 1987, 35 (03): : A534 - A534
  • [9] PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL WITH BN-52021, A SPECIFIC ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    FOEGH, ML
    KHIRABADI, BS
    ROWLES, JR
    BRAQUET, P
    RAMWELL, PW
    TRANSPLANTATION, 1986, 42 (01) : 86 - 88
  • [10] THE PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST BN52021 DECREASES THE SEVERITY OF HYPOXIC-ISCHEMIC BRAIN INJURY IN THE IMMATURE RAT
    LIU, XH
    SILVERSTEIN, FS
    BARKS, JDE
    PEDIATRIC RESEARCH, 1995, 37 (04) : A382 - A382
12345